Skip to content
LongevityGraded

Review

Oak Review: NAD+ at $175 a Month, Peptides Priced Later

Oak now prices NAD+ at $175 a month with the review, messaging and shipping included. Sermorelin and tesamorelin are priced after the assessment.

Researched & graded by · Lead Reviews Analyst
Last graded
On this page

The one-sentence version

Oak is often described as an injectable-only GLP-1 shop with flat dose pricing. It is more than that. Oak runs six live programs, and two of them are squarely this site's subject: an Anti-Aging program (NAD+, glutathione, MIC+B12 and metformin) and a sermorelin/tesamorelin program, with topical NAD+ and copper peptides in a compounded skincare line besides. It also puts the clinician review and ongoing coaching inside the price with no membership fee, which is more than several providers here manage. Its longevity page now publishes a price for NAD+, $175 a month, "regularly $199," with the provider review, ongoing messaging and shipping included; sermorelin and tesamorelin are still priced only after the free assessment2. It names no pharmacy and no clinician, and the GLP-1 prices it publishes come in five mutually inconsistent versions. It grades A, 12 points out of 14. Oak is a partner here.

What it actually sells

Oak's checkout lists six active programs. Naming them matters, because the public positioning names two:

  • GLP-1 — compounded semaglutide and tirzepatide, with optional compounded B6 or B12
  • Phentermine — oral
  • Anti-Aging — MIC+B12 injections, glutathione, NAD+ and metformin
  • "Semorelin" (spelled that way in Oak's own catalog) — injectable sermorelin and tesamorelin
  • Erectile dysfunction — sildenafil, tadalafil, Trimix
  • Skin care — tretinoin, adapalene and retinol, peptide and growth-factor topicals including Argireline and GHK-Cu, topical estriol, topical NAD+ and resveratrol, niacinamide, azelaic acid and AHAs

The homepage nav carries the same thing in plain sight: NAD+ & Glutathione, Sermorelin Peptides, Oral Meds, Women's Health, Tadalafil. So "GLP-1 only" was never an accurate description.

Two things are not for sale, whatever else you may read. There is no methylene blue, no TRT or HRT (men's health here is erectile dysfunction), and no BPC-157 or TB-500 — the copper peptides are topical. And the two supplement packs sitting in Oak's catalog (a "Gut Health Vitamin Pack" and a "Longevity Vitamin Pack" of NMN, AKG, glycine, hyaluronic acid, omega-3 and vitamin D) are both flagged inactive and are not purchasable, so they are not listed anywhere on this site as products.

What it actually costs

NAD+ has a price now. Oak's longevity page shows "NAD+ FROM $175/mo" and a card reading "$175/mo $199." Its FAQ spells it out: "NAD+ is $175 a month, regularly $199. Sermorelin and Tesamorelin pricing is shown after your free assessment. Every plan includes your provider review, ongoing messaging support and free discreet shipping. No insurance required." A footnote adds that $175 a month is the current price for a one-month supply and the regular price is $1992. That is one all-in figure, published before you commit, which is what our rubric rewards. Budget at $199 in case the current price ends.

Sermorelin and tesamorelin are not priced. Both cards read "Pricing after your free assessment." This review does not estimate them. There is no honest way to back-solve a peptide price from an NAD+ or semaglutide figure, and doing it would put a number on this page that Oak has never quoted. Glutathione, MIC+B12 and metformin, which sit in Oak's Anti-Aging program, have no published price either.

The homepage says something else again. Its longevity tile advertises "from $99/mo," a figure no longevity product page shows. Use the $175 on the longevity page.

What Oak publishes for GLP-1, five times, differently:

What Oak publishes, and where

NAD+ injection$175/mo (regularly $199)Longevity page and FAQ
Sermorelin, tesamorelinPriced after the assessmentLongevity page
Glutathione, MIC+B12, metforminPricing not publishedQuoted after the quiz and clinician approval
Longevity (homepage tile)From $99/moHomepage; no product page shows it
GLP-1$119 sema / $185 tirzHomepage hero and product cards
GLP-1$133 sema / $199 tirzPage description, OG and Twitter metadata
GLP-1$167/mo"How Oak Compares" table, homepage and /product
GLP-1$190/moThe same table on /weightloss and /weight-loss
GLP-1$119/monthHomepage FAQ
From Oak's published pricing. NAD+ is the only longevity product with a price.

That is one site telling a shopper five things. The hero and the FAQ agree at $119; the metadata that populates a Google result or a shared link says $133; the comparison table on the homepage says $167; the same comparison table on /weight-loss says $190. Anchor on the hero — $119 semaglutide, $185 tirzepatide, "One price · All dosages · No subscriptions" — and know that the spread exists.

Running over the top of all of it: an unpriced "$200 off — new patient offer" and a "Save up to 60% vs. retail pricing" banner, neither with published mechanics.

What Oak gets right, and it is not nothing

The consultation and the coaching are inside the price. Oak's own comparison table prints "Membership Fees: None" against "$50–$99/mo" for other telehealth. Its FAQ says its programs come with "no hidden membership fees, no surprise charges, and free shipping." Approval is asynchronous — a written form, no video call required — so there is no visit to bill for. And support is stated as free and ongoing: "Free Health Coaching" runs site-wide, its three-step explainer says "Support is always available for free," and its FAQ says "Oak's Care Team is available throughout your treatment to answer questions, adjust your dose, and support your progress." Those are four of the points Oak earns beyond its longevity line and its NAD+ price, and they are earned on published statements rather than inference.

Oak holds no FDA warning letter. FDA's warning-letter index has no letter against Oak or its clinical network.

The four contradictions

1. Four legal entities on one terms page — and two more in the footer. Oak's /terms-of-use carries Oak Longevity Holdings Corp, Oak Longevity Corp and Leaf Longevity Holdings Corp. DBA Oak Longevity, and then a second, separately dated Terms of Use appended below the first naming Oaklovesyou LLC. The homepage footer adds Flow Longevity Holdings Corp and Mito Health Holdings Corp to the SMS consent, and the copyright line says Leaf Longevity Holdings Corp. Which entity you are contracting with is not a question a customer should have to research.

2. The state list is a circular reference to a page that does not exist. One Terms document says Oak provides its services "to 45 states of the U.S." The second says eligibility depends on a "States Where We Currently Operate" list "found in our FAQ." There is no FAQ page. So the authoritative state list points at nothing, and 45 is the only number a reader can act on.

3. The Women's Health tile is wired to the NAD+ intake. The homepage ships a live Women's Health tile whose link opens the Anti-Aging (NAD+/glutathione) questionnaire. There is no women's-health questionnaire in the catalog at all — and /weight-loss and /start simultaneously label Men's and Women's Health "Coming Soon." A woman clicking a tile marked Women's Health lands in an NAD+ intake, on a site that elsewhere says the product has not launched.

4. "No subscriptions" versus the subscription. The hero says "No subscriptions." The Terms describe a "Subscription fee" that "may change from time to time" and a subscription you can cancel. Both are current.

And two things a buyer should price in. Refunds are a hard no once your prescription reaches the pharmacy — Oak's Terms say the order "can no longer be canceled and is non-refundable… even if you attempt to stop, hold, reroute, return, or cancel the shipment directly with FedEx" — with AAA binding arbitration and class actions waived. And Oak's own patient counts do not agree with each other: "10,000+ Satisfied Patients" and "Trusted by 5,000+ members" on the homepage, "Trusted by 50,000+" on /product.

Who prescribes, and who fills it

Nobody is named. Oak identifies no medical director, no prescribing clinician and no NPI numbers, and it names no dispensing pharmacy. What it does say, in its FAQ, is: "At Oak, every prescription is reviewed by a board-certified provider and fulfilled through licensed U.S. compounding pharmacies that comply with state and federal pharmacy regulations." That is a description of an unnamed set — the middle case in our pharmacy ladder's own wording — and it scores zero, the same as saying nothing, because it identifies neither a facility nor a compounding standard.

On the certification badge, be precise. Oak's footer renders a LegitScript badge as a local image and links only the LegitScript checker tool. There is no seal ID anywhere on the site, so there is nothing for a reader to look up and this review makes no claim in either direction about Oak's certification status. Where a provider publishes its seal ID, we print the identifier — Care Bare Rx and Breeze Meds both do. A badge with no identifier behind it is a graphic.

What the research says, in short

Oak's longevity line mixes compounds with very different evidence behind them, and it is worth separating them.

NAD+. Human evidence that NAD+ slows aging is thin, and thinnest for injections, the route Oak sells. See NAD+ for longevity.

Sermorelin and tesamorelin. Both raise growth hormone. Tesamorelin's FDA approval is for excess belly fat in people with HIV, not healthy aging, and there is no good evidence that either one helps healthy adults age better. See peptides for longevity.

Metformin is the one on the list with a genuine longevity literature behind it, and it is still not settled: the large trial meant to answer the question has not reported, and most of the case comes from people with diabetes. Read what metformin's longevity evidence actually shows before treating its presence on a menu as a reason to buy.

All of it is compounded and none of it is FDA-approved for anti-aging; FDA's own position is that compounded drugs are not FDA-approved and it does not verify their safety, effectiveness or quality before they are marketed1.

Before you start

Six things to settle before you start with Oak

  • NAD+ is $175 a month now, regularly $199 — budget for both. For sermorelin, tesamorelin and the rest, treat the intake as a quotation request.
  • Get your state confirmed. One Terms document says 45 states; the other defers to an FAQ page that does not exist — /faq, /faqs, /help and /states all 404.
  • Ask which entity you are contracting with. Four appear on the Terms page and two more in the homepage footer.
  • Know the refund door closes early: once the pharmacy has your order it "can no longer be canceled and is non-refundable".
  • If you use the "Women's Health" tile, expect the NAD+ and glutathione intake — that is where it goes, and no women's-health questionnaire exists in the catalog.
  • Do not read the footer's LegitScript badge as a checkable certification: it is a local image with no seal ID.

Where it's weak, and who should skip it

Skip it if you want sermorelin or tesamorelin and need the price before you hand over a medical history, because Oak shows it only after the assessment. Skip it if you need to confirm your own state, because the document that would tell you resolves to a 404. Skip it if you want to know who is prescribing or who is compounding, because Oak names neither. And skip it if a hard no-refund policy once the pharmacy has your prescription is a risk you will not take.

Consider it if you want NAD+ at a published $175 a month with the review, messaging and shipping inside it, or if the breadth is what you want — glutathione, MIC+B12 and metformin under one intake, with sermorelin and tesamorelin beside them, no membership fee, free coaching and an asynchronous approval. For anything but NAD+, treat the intake as a quotation request. Get the program price, the dose and your state in writing before you agree to anything, and remember that the refund door closes the moment the pharmacy receives the order.

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). Oak takes the full four for its longevity line — an Anti-Aging program and a sermorelin/tesamorelin program are exactly what this site exists to rank. It takes two for clinical oversight, because there is no membership and no consult fee anywhere in the published price structure, and two for human support, on free coaching and a care team published as available throughout treatment. It takes all four for price transparency, because NAD+ now carries one published monthly figure with the provider review, messaging and shipping inside it. It takes zero for pharmacy, because an unnamed set of "licensed U.S. compounding pharmacies" identifies no facility and states no standard. Twelve out of fourteen: an A.

The A rests on the NAD+ price alone, so go in clear-eyed: the peptides are unpriced, the GLP-1 prices disagree with each other, and the state list points at a page that does not exist. Naming its pharmacies would take Oak to thirteen. The full graded field is at our provider rankings, the scoring is set out in how we grade, and what this category costs generally is in longevity clinic cost.

Compare Oak with

We may earn a commission through these links, at no extra cost to you. Disclosure

B

Featured partner

CoreAge Rx $93–$99/mo (starting rates)

Visit CoreAge Rx

See every graded provider ↗

Frequently asked questions

How much does Oak's NAD+ or sermorelin cost?

NAD+ is $175 a month, which Oak calls its current price against a regular $199, and its FAQ says every plan includes the provider review, ongoing messaging support and free discreet shipping, with no insurance required. Sermorelin and tesamorelin are priced only after the free assessment, and we are not going to estimate them. Glutathione, MIC+B12 and metformin carry no published price either. The homepage tile advertises longevity 'from $99/mo', a figure no longevity product page shows, so go by the $175 on the longevity page. Oak's GLP-1 prices appear in five different versions across the site, from $119 to $190 a month.

Does Oak sell NAD+ and peptides, or only GLP-1?

Both. Oak's own checkout lists six live programs. Two are longevity programs: an Anti-Aging program whose consent text names MIC+B12 injections, glutathione, NAD+ and metformin, and a sermorelin program — spelled "Semorelin" in Oak's own catalog — covering injectable sermorelin and tesamorelin. A compounded skincare program adds topical NAD+, resveratrol and copper-peptide and growth-factor formulations including Argireline and GHK-Cu. The homepage navigation shows the same thing in plain sight, with "NAD+ & Glutathione" and "Sermorelin Peptides" listed beside weight loss. What Oak does not sell is methylene blue, testosterone or hormone replacement of any kind, or injectable BPC-157 or TB-500. Two supplement packs exist in its catalog but are flagged inactive and cannot be bought.

Which states does Oak serve?

Its own answer contradicts itself and one half of it points at a page that does not exist. The first Terms of Use document says "OAK is providing the Services of our Site to 45 states of the U.S., unless a particular state has laws that interfere with our provisioning of a certain product or service in that state." A second, separately dated Terms of Use appended below it says eligibility depends on a "States Where We Currently Operate" list "found in our FAQ" — and Oak has no FAQ page. So the document that is supposed to carry the authoritative list refers you to nothing, and "45 states" is the only figure a reader can act on, with no list of which 45. Confirm your own state with support before starting.

Is Oak legit?

It transacts and it holds no FDA warning letter — FDA's index has no letter against Oak or its clinical network. What it will not tell you is who is involved. No medical director, no prescribing clinician and no NPI numbers are published anywhere on the site, and no dispensing pharmacy is named; the strongest statement is that prescriptions are "fulfilled through licensed U.S. compounding pharmacies that comply with state and federal pharmacy regulations", which identifies no facility and states no compounding standard. Its footer carries a LegitScript badge, but as a local image linking the checker tool with no seal identifier — so there is nothing for a reader to verify, and this review makes no claim about its certification status in either direction. Add the four legal entities on its Terms page and two more in its footer, and the honest summary is that Oak is a real operator with unusually thin disclosure about itself.

Why does Oak's "Women's Health" link open an NAD+ intake?

Because the tile is wired to the wrong program. Oak's homepage ships a live Women's Health tile whose link opens the Anti-Aging questionnaire — the NAD+ and glutathione intake — and there is no women's-health questionnaire anywhere in Oak's catalog. At the same time, /weight-loss and /start both label Men's and Women's Health "Coming Soon". So one part of the site sells a product another part says has not launched, and the button for it takes you somewhere else entirely. It is worth knowing before you fill anything in: if you click Women's Health and find yourself answering questions about cellular energy and glutathione, that is not a mistake you made. Nothing about this affects the medicine Oak dispenses, but it is a fair signal of how closely the storefront is being maintained.

Why does Oak grade A?

It scores twelve out of fourteen and drops both missing points on pharmacy disclosure, because "licensed U.S. compounding pharmacies" names no facility and states no compounding standard. Price transparency, which our rubric weights double, scores the full four: NAD+ is published at $175 a month with the provider review, messaging and shipping included, before you commit. Everything else scores full marks: four points for a genuine longevity line, since an Anti-Aging program of NAD+, glutathione, MIC+B12 and metformin plus a sermorelin and tesamorelin program is exactly what this site exists to rank; two for clinical oversight, since there is no membership fee and no consult fee anywhere in the published price structure and its own comparison table prints "Membership Fees: None"; and two for human support, on free health coaching and a care team published as available throughout treatment. The A rests on the NAD+ price alone; sermorelin and tesamorelin are still priced only after the assessment.

References

  1. U.S. Food and Drug Administration (2025). Compounding and the FDA: Questions and Answers ('Compounded drugs are not FDA-approved'; 503A pharmacies are not subject to CGMP requirements). FDA — Human Drug Compounding.
  2. Oak (2026). Longevity treatments — NAD+, sermorelin and tesamorelin, prices and FAQ. Oak website.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.